National AMD audit (NOD)
Launched in 2021, the Age-related Macular Degeneration (AMD) audit aims to improve the treatment and care that patients receive in the UK.
This commissioning guidance sets out the principles and recommended minimum standards for age-related macular degeneration services. It is intended to reduce unwarranted variation across services and support local pathway design, capacity planning and quality improvement. The document covers diagnosis, referral, treatment, monitoring, governance, audit, workforce and support services, with a strong focus on timely access for suspected wet AMD and joined-up working across hospital, community and primary care settings.
If you want more information the evidence that underpins the AMD commissioning guidance is also available. It includes the literature search, epidemiology, diagnostic evidence, treatment evidence, service model considerations and full references. It is useful for readers who need the rationale behind the recommendations, including commissioners, clinicians, service leads and those developing local pathways or business cases for AMD services.
Launched in 2021, the Age-related Macular Degeneration (AMD) audit aims to improve the treatment and care that patients receive in the UK.
Provides evidence-based recommendations for the diagnosis and management of retinal vein occlusion, reflecting advances in imaging and the growing use of intravitreal therapies.